{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:48:27Z","timestamp":1788187707468,"version":"build-2803163510"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Domp\u00e8 Farmaceutici SpA"},{"name":"ProRETT Ricerca","award":["F\/180021\/01\/X43"],"award-info":[{"award-number":["F\/180021\/01\/X43"]}]},{"name":"European Union Regional Development Fund"},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>MECP2 deficiency causes a broad spectrum of neuropsychiatric disorders that can affect both genders. Rett syndrome is the most common and is characterized by an apparently normal growth period followed by a regression phase in which patients lose most of their previously acquired skills. After this dramatic period, various symptoms progressively appear, including severe intellectual disability, epilepsy, apraxia, breathing abnormalities and motor deterioration. MECP2 encodes for an epigenetic transcription factor that is particularly abundant in the brain; consequently, several transcriptional defects characterize the Rett syndrome brain. The well-known deficiency of several neurotrophins and growth factors, together with the positive effects exerted by trofinetide, a synthetic analogue of insulin-like growth factor 1, in Rett patients and in mouse models of Mecp2 deficiency, prompted us to investigate the therapeutic potential of nerve growth factor.<\/jats:p>\n               <jats:p>Initial in vitro studies demonstrated a healing effect of recombinant human GMP-grade NGF (rhNGF) on neuronal maturation and activity in cultured Mecp2-null neurons. Subsequently, we designed in vivo studies with clear translational potential using intranasally administered rhNGF already used in the clinic. The efficacy of rhNGF in vivo in Mecp2-null hemizygous male mice and heterozygous female mice was assessed. General well-being was evaluated by a conventional phenotypic score and motor performance through the Pole and Beam Walking tests, while cognitive function and interaction with the environment were measured by the Novel Object Recognition test and the Marble Burying test, respectively. At the end of the treatment, mouse cortices were dissected and bulk RNA sequencing was performed to identify the molecular pathways involved in the protective effects of rhNGF.<\/jats:p>\n               <jats:p>In both male and female mouse models of Rett syndrome, rhNGF exerted positive effects on cognitive and motor functions. In male hemizygous mice, which suffer from significantly more severe and rapidly advancing symptoms, the drug\u2019s ability to slow the disease\u2019s progression was more pronounced.<\/jats:p>\n               <jats:p>The unbiased research for the molecular mechanisms triggering the observed benefits revealed a strong positive effect on gene sets related to oxidative phosphorylation, mitochondrial structure and function. These results were validated by demonstrating the drug\u2019s ability to improve mitochondrial structure and respiration in Mecp2-null cerebral cortices. Furthermore, Gene Ontology analyses indicated that NGF exerted the expected improvement in neuronal maturation.<\/jats:p>\n               <jats:p>We conclude that intranasal administration of rhNGF is a non-invasive and effective route of administration for the treatment of Rett syndrome and possibly for other neurometabolic disorders with overt mitochondrial dysfunction.<\/jats:p>","DOI":"10.1093\/brain\/awae291","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T06:27:01Z","timestamp":1726813621000},"page":"845-860","source":"Crossref","is-referenced-by-count":11,"title":["Clinical-grade intranasal NGF fuels neurological and metabolic functions of <i>Mecp2<\/i>-deficient mice"],"prefix":"10.1093","volume":"148","author":[{"given":"Diego","family":"Pozzer","sequence":"first","affiliation":[{"name":"Neuroscience Division, IRCCS San Raffaele Scientific Institute , Milan I-20132 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Indrigo","sequence":"additional","affiliation":[{"name":"Neuroscience Division, IRCCS San Raffaele Scientific Institute , Milan I-20132 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Breccia","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Segrate (Milan) I-20054 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Florio","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Segrate (Milan) I-20054 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Aurora","family":"Franchino","sequence":"additional","affiliation":[{"name":"Neuroscience Division, IRCCS San Raffaele Scientific Institute , Milan I-20132 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"De Rocco","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Segrate (Milan) I-20054 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8095-8208","authenticated-orcid":false,"given":"Francesca","family":"Maltecca","sequence":"additional","affiliation":[{"name":"Neuroscience Division, IRCCS San Raffaele Scientific Institute , Milan I-20132 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Fadda","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, University of Verona , Verona 37134 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6101-1550","authenticated-orcid":false,"given":"Marzia","family":"Rossato","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, University of Verona , Verona 37134 ,","place":["Italy"]},{"name":"Genartis s.r.l. , Verona 37126 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Aramini","sequence":"additional","affiliation":[{"name":"R&D Domp\u00e9 Farmaceutici SpA, Via Campo di Pile , 67100, L'Aquila ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Allegretti","sequence":"additional","affiliation":[{"name":"R&D Domp\u00e9 Farmaceutici SpA, Via Campo di Pile , 67100, L'Aquila ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelisa","family":"Frasca","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Segrate (Milan) I-20054 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2196-9430","authenticated-orcid":false,"given":"Lidia","family":"De Filippis","sequence":"additional","affiliation":[{"name":"R&D Domp\u00e9 Farmaceutici SpA, Via S. Lucia , 20122, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0820-3155","authenticated-orcid":false,"given":"Nicoletta","family":"Landsberger","sequence":"additional","affiliation":[{"name":"Neuroscience Division, IRCCS San Raffaele Scientific Institute , Milan I-20132 ,","place":["Italy"]},{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Segrate (Milan) I-20054 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"2025030619382406200_awae291-B1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-323-85654-6.00002-2","volume-title":"Neurobiology of brain disorders","author":"Frasca","year":"2023","edition":"2nd edn"},{"key":"2025030619382406200_awae291-B2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: From clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"2025030619382406200_awae291-B3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.pediatrneurol.2015.06.003","article-title":"The changing face of survival in Rett syndrome and MECP2-related disorders","volume":"53","author":"Tarquinio","year":"2015","journal-title":"Pediatr Neurol"},{"key":"2025030619382406200_awae291-B4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajmg.b.32707","article-title":"The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2","volume":"180","author":"Neul","year":"2019","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2025030619382406200_awae291-B5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat Genet"},{"key":"2025030619382406200_awae291-B6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuropharm.2012.08.010","article-title":"Rett syndrome treatment in mouse models: Searching for effective targets and strategies","volume":"68","author":"Ricceri","year":"2013","journal-title":"Neuropharmacology"},{"key":"2025030619382406200_awae291-B7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"issue":"0 0","key":"2025030619382406200_awae291-B8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuropharm.2013.03.024","article-title":"BDNF deregulation in Rett syndrome","volume":"76 Pt C","author":"Li","year":"2014","journal-title":"Neuropharmacology"},{"key":"2025030619382406200_awae291-B9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnen\/59.10.889","article-title":"Reduced nerve growth factor in Rett syndrome postmortem brain tissue","volume":"59","author":"Lipani","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"2025030619382406200_awae291-B10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2015.01.011","article-title":"Dendritic spine dysgenesis in autism related disorders","volume":"601","author":"Phillips","year":"2015","journal-title":"Neurosci Lett"},{"key":"2025030619382406200_awae291-B11","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1523\/JNEUROSCI.1810-06.2006","article-title":"Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice","volume":"26","author":"Wang","year":"2006","journal-title":"J Neurosci"},{"key":"2025030619382406200_awae291-B12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nbd.2008.12.011","article-title":"Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations","volume":"34","author":"Larimore","year":"2009","journal-title":"Neurobiol Dis"},{"key":"2025030619382406200_awae291-B13","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J Neurosci"},{"key":"2025030619382406200_awae291-B14","doi-asserted-by":"crossref","first-page":"e12433","DOI":"10.15252\/emmm.202012433","article-title":"The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes","volume":"13","author":"Scaramuzza","year":"2021","journal-title":"EMBO Mol Med"},{"key":"2025030619382406200_awae291-B15","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1523\/JNEUROSCI.0865-11.2012","article-title":"A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome","volume":"32","author":"Schmid","year":"2012","journal-title":"J Neurosci"},{"key":"2025030619382406200_awae291-B16","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1073\/pnas.1206093109","article-title":"Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome","volume":"109","author":"Deogracias","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025030619382406200_awae291-B17","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025030619382406200_awae291-B18","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","article-title":"Trofinetide for the treatment of Rett syndrome: A randomized phase 3 study","volume":"29","author":"Neul","year":"2023","journal-title":"Nat Med"},{"key":"2025030619382406200_awae291-B19","doi-asserted-by":"crossref","first-page":"1284035","DOI":"10.3389\/fphar.2023.1284035","article-title":"Trofinetide-a new chapter in rett syndrome's treatment","volume":"14","author":"Furqan","year":"2023","journal-title":"Front Pharmacol"},{"key":"2025030619382406200_awae291-B20","first-page":"148","article-title":"Levels of cerebrospinal fluid nerve-growth factor differ in infantile autism and Rett syndrome","volume":"41","author":"Riikonen","year":"1999","journal-title":"Dev Med Child Neurol"},{"key":"2025030619382406200_awae291-B21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.physbeh.2009.12.025","article-title":"Cognitive and social functions and growth factors in a mouse model of Rett syndrome","volume":"100","author":"Schaevitz","year":"2010","journal-title":"Physiol Behav"},{"key":"2025030619382406200_awae291-B22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbr.2011.03.051","article-title":"Cholinergic hypofunction in MeCP2-308 mice: Beneficial neurobehavioural effects of neonatal choline supplementation","volume":"221","author":"Ricceri","year":"2011","journal-title":"Behav Brain Res"},{"key":"2025030619382406200_awae291-B23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/mp.2011.155","article-title":"QTL replication and targeted association highlight the nerve growth factor gene for nonverbal communication deficits in autism spectrum disorders","volume":"18","author":"Lu","year":"2013","journal-title":"Mol Psychiatry"},{"key":"2025030619382406200_awae291-B24","doi-asserted-by":"crossref","first-page":"784040","DOI":"10.1155\/2012\/784040","article-title":"NGF, brain and behavioral plasticity","volume":"2012","author":"Berry","year":"2012","journal-title":"Neural Plast"},{"key":"2025030619382406200_awae291-B25","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/ijms18040828","article-title":"Delineating the common biological pathways perturbed by ASD's genetic etiology: Lessons from network-based studies","volume":"18","author":"Oron","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2025030619382406200_awae291-B26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nn1218","article-title":"Neural activity and the dynamics of central nervous system development","volume":"7","author":"Hua","year":"2004","journal-title":"Nat Neurosci"},{"key":"2025030619382406200_awae291-B27","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1080\/02699052.2017.1376760","article-title":"Intranasal nerve growth factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report","volume":"31","author":"Chiaretti","year":"2017","journal-title":"Brain Inj"},{"key":"2025030619382406200_awae291-B28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13062-023-00418-1","article-title":"Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome","volume":"18","author":"Gatto","year":"2023","journal-title":"Biol Direct"},{"key":"2025030619382406200_awae291-B29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13062-023-00379-5","article-title":"Combined treatment of nerve growth factor and transcranical direct current stimulations to improve outcome in children with vegetative state after out-of-hospital cardiac arrest","volume":"18","author":"Curatola","year":"2023","journal-title":"Biol Direct"},{"key":"2025030619382406200_awae291-B30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/brain\/awad282","article-title":"Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome","volume":"147","author":"Tiberi","year":"2024","journal-title":"Brain"},{"key":"2025030619382406200_awae291-B31","doi-asserted-by":"crossref","first-page":"e0153473","DOI":"10.1371\/journal.pone.0153473","article-title":"MeCP2 related studies benefit from the use of CD1 as genetic background","volume":"11","author":"Cobolli Gigli","year":"2016","journal-title":"PLoS One"},{"key":"2025030619382406200_awae291-B32","doi-asserted-by":"crossref","first-page":"e10270","DOI":"10.15252\/emmm.201910270","article-title":"MECP2 mutations affect ciliogenesis: A novel perspective for Rett syndrome and related disorders","volume":"12","author":"Frasca","year":"2020","journal-title":"EMBO Mol Med"},{"key":"2025030619382406200_awae291-B33","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: An ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"2025030619382406200_awae291-B34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: Ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2025030619382406200_awae291-B35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025030619382406200_awae291-B36","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","article-title":"Heavy-tailed prior distributions for sequence count data: Removing the noise and preserving large differences","volume":"35","author":"Zhu","year":"2019","journal-title":"Bioinformatics"},{"key":"2025030619382406200_awae291-B37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"2025030619382406200_awae291-B38","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025030619382406200_awae291-B39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/brain\/awad340","article-title":"Sustained OMA1-mediated integrated stress response is beneficial for spastic ataxia type 5","volume":"147","author":"Franchino","year":"2024","journal-title":"Brain"},{"key":"2025030619382406200_awae291-B40","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41419-023-06100-8","article-title":"Intranasal delivery of NGF rescues hearing impairment in aged SAMP8 mice","volume":"14","author":"Castelli","year":"2023","journal-title":"Cell Death Dis"},{"key":"2025030619382406200_awae291-B41","doi-asserted-by":"crossref","first-page":"109296","DOI":"10.1016\/j.isci.2024.109296","article-title":"Mecp2 knock-out astrocytes affect synaptogenesis by interleukin 6 dependent mechanism","volume":"27","author":"Albizzati","year":"2024","journal-title":"iScience"},{"key":"2025030619382406200_awae291-B42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1471-4159.2012.07681.x","article-title":"Resistance to trophic neurite outgrowth of sensory neurons exposed to insulin","volume":"121","author":"Singh","year":"2012","journal-title":"J Neurochem"},{"key":"2025030619382406200_awae291-B43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuropharm.2013.07.023","article-title":"Chronic intracerebroventricular infusion of nerve growth factor improves recognition memory in the rat","volume":"75","author":"Birch","year":"2013","journal-title":"Neuropharmacology"},{"key":"2025030619382406200_awae291-B44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/brain\/aww271","article-title":"The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor","volume":"140","author":"Capsoni","year":"2017","journal-title":"Brain"},{"key":"2025030619382406200_awae291-B45","doi-asserted-by":"crossref","first-page":"754502","DOI":"10.3389\/fphar.2021.754502","article-title":"Intranasal delivery of nerve growth factor in neurodegenerative diseases and neurotrauma","volume":"12","author":"Manni","year":"2021","journal-title":"Front Pharmacol"},{"key":"2025030619382406200_awae291-B46","doi-asserted-by":"crossref","first-page":"106083","DOI":"10.1016\/j.nbd.2023.106083","article-title":"A comprehensive longitudinal study of magnetic resonance imaging identifies novel features of the Mecp2 deficient mouse brain","volume":"180","author":"Carli","year":"2023","journal-title":"Neurobiol Dis"},{"key":"2025030619382406200_awae291-B47","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"2025030619382406200_awae291-B48","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/npp.2014.105","article-title":"Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome","volume":"39","author":"De Filippis","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"2025030619382406200_awae291-B49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10882-015-9427-3","article-title":"Pain experience and expression in Rett syndrome: Subjective and objective measurement approaches","volume":"27","author":"Barney","year":"2015","journal-title":"J Dev Phys Disabil"},{"key":"2025030619382406200_awae291-B50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2016.05.033","article-title":"Cell peripheral mechanosensory neuron dysfunction underlies tactile and behavioral deficits in mouse models of ASDs","volume":"166","author":"Orefice","year":"2016","journal-title":"Cell"},{"key":"2025030619382406200_awae291-B51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/ijms19010097","article-title":"Motor, somatosensory, viscerosensory and metabolic impairments in a heterozygous female rat model of Rett syndrome","volume":"19","author":"Bhattacherjee","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2025030619382406200_awae291-B52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.resp.2013.06.022","article-title":"Breathing challenges in Rett syndrome: Lessons learned from humans and animal models","volume":"189","author":"Ramirez","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"2025030619382406200_awae291-B53","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/biom11070967","article-title":"Transcriptomic and epigenomic landscape in Rett syndrome","volume":"11","author":"Marano","year":"2021","journal-title":"Biomolecules"},{"key":"2025030619382406200_awae291-B54","first-page":"956","article-title":"Mitochondrial proteome changes in Rett syndrome","volume":"12","author":"Golubiani","year":"2023","journal-title":"Biology (Basel)"},{"key":"2025030619382406200_awae291-B55","doi-asserted-by":"crossref","first-page":"6154080","DOI":"10.1155\/2016\/6154080","article-title":"Developmental dynamics of Rett syndrome","volume":"2016","author":"Feldman","year":"2016","journal-title":"Neural Plast"},{"key":"2025030619382406200_awae291-B56","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/S0387-7604(01)00332-1","article-title":"Rett syndrome neuropathology review 2000","volume":"23 Suppl 1","author":"Armstrong","year":"2001","journal-title":"Brain Dev"},{"key":"2025030619382406200_awae291-B57","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/WNL.45.8.1581","article-title":"Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome","volume":"45","author":"Bauman","year":"1995","journal-title":"Neurology"},{"key":"2025030619382406200_awae291-B58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/cne.22009","article-title":"Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: Evidence for disruption of neuronal networks","volume":"514","author":"Belichenko","year":"2009","journal-title":"Comp Neurol"},{"key":"2025030619382406200_awae291-B59","doi-asserted-by":"crossref","first-page":"108790","DOI":"10.1016\/j.abb.2021.108790","article-title":"Impaired mitochondrial quality control in Rett syndrome","volume":"700","author":"Crivellari","year":"2021","journal-title":"Arch Biochem Biophys"},{"key":"2025030619382406200_awae291-B60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2020.05.014","article-title":"Proteomic profiling reveals mitochondrial alterations in Rett syndrome","volume":"155","author":"Cicaloni","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"10 Pt A","key":"2025030619382406200_awae291-B61","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.bbadis.2015.07.014","article-title":"Impaired enzymatic defensive activity, mitochondrial dysfunction and proteasome activation are involved in RTT cell oxidative damage","volume":"1852","author":"Cervellati","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"2025030619382406200_awae291-B62","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1186\/s12967-023-04622-5","article-title":"Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome","volume":"21","author":"Musokhranova","year":"2023","journal-title":"J Transl Med"},{"key":"2025030619382406200_awae291-B63","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1073\/pnas.88.12.5144","article-title":"Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor","volume":"88","author":"Taiwo","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025030619382406200_awae291-B64","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.neuron.2008.10.010","article-title":"Mitochondria in neuroplasticity and neurological disorders","volume":"60","author":"Mattson","year":"2008","journal-title":"Neuron"},{"key":"2025030619382406200_awae291-B65","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/cdd.2016.36","article-title":"Metabolic reprogramming during neuronal differentiation","volume":"23","author":"Agostini","year":"2016","journal-title":"Cell Death Differ"},{"key":"2025030619382406200_awae291-B66","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41419-018-0429-9","article-title":"Differentiation by nerve growth factor (NGF) involves mechanisms of crosstalk between energy homeostasis and mitochondrial remodeling","volume":"9","author":"Martorana","year":"2018","journal-title":"Cell Death Dis"},{"key":"2025030619382406200_awae291-B67","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/febs.17083","article-title":"Fusion-fission-mitophagy cycling and metabolic reprogramming coordinate nerve growth factor (NGF)-dependent neuronal differentiation","volume":"291","author":"Goglia","year":"2024","journal-title":"FEBS J"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awae291\/59206263\/awae291.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/148\/3\/845\/59206263\/awae291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/148\/3\/845\/59206263\/awae291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T19:45:49Z","timestamp":1741290349000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/148\/3\/845\/7762234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9,20]]},"published-print":{"date-parts":[[2025,3,6]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awae291","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,9,20]]}}}